Semaglutide pen 10mg

Semaglutide 10mg Research Pen 

The iVy Semaglutide 10mg Research Pen is manufactured to high purity standards and supplied exclusively for laboratory and scientific research applications.

Each pen contains 10mg of research-grade Semaglutide, produced under strict quality control to ensure consistency, purity, and reliability for qualified research professionals.

Product Specifications

Compound: Semaglutide

Strength: 10mg

Format: Liquid filled pen. 

Purity: ≥99%

Storage: Store refrigerated at 2–8°C. Do not freeze.

Research Use Only

Package Contents

1 × Semaglutide 10mg Research Pen 

12 × injection needles

Important Notice

This product is supplied strictly for laboratory and scientific research purposes only. It is not intended for human or veterinary use, diagnosis, treatment, or prevention of any disease. Purchasers are responsible for ensuring compliance with all applicable laws and regulations in their jurisdiction.

ℹ️ℹ️ℹ️ℹ️

What it is:

Semaglutide is a prescription medication that belongs to a class of drugs called GLP-1 receptor agonists. It is approved to treat type 2 diabetes and chronic weight management in eligible adults (and some adolescents for obesity).

Storage Instructions

Mixed medication should be refrigerated  immediately. 

What it does:

 Reduces appetite and helps you feel fuller for longer.

 Slows stomach emptying, helping control hunger.

 Improves blood sugar control by increasing insulin release when blood sugar is high.

 Reduces glucagon (a hormone that raises blood sugar).

Can lead to significant weight loss when combined with a healthy diet and physical activity.

Potential benefits:

 Significant weight loss.

 Improved blood sugar control.

 Reduced risk of major cardiovascular events in certain people with type 2 diabetes or obesity and cardiovascular disease.

 Improves blood pressure and cholesterol as weight decreases.

Possible side effects: 

Common 

Nausea.

Vomiting.

Diarrhea.

Constipation.

Stomach pain.

Indigestion or heartburn.

Decreased appetite.

Fatigue.

Serious (less common):

Pancreatitis (inflammation of the pancreas).

Gallbladder problems (including gallstones).

Kidney problems due to dehydration.

Severe allergic reactions.

Low blood sugar (mainly when used with insulin or sulfonylureas).

Possible increased risk of thyroid C-cell tumors (seen in animal studies; avoid if you or your family have a history of medullary thyroid cancer or Multiple Endocrine Neoplasia syndrome type 2).

How it is taken:

Semaglutide is usually given as a once-weekly injection. It should be started at a low dose and increased gradually to reduce side effects.

Who should avoid or use caution:

 People with a personal or family history of medullary thyroid cancer or MEN2.

 People with a history of pancreatitis should discuss the risks with their healthcare provider.

 Use during pregnancy is generally not recommended.

Key point:

Semaglutide is a well-studied, prescription GLP-1 medication that has been shown to be effective for weight loss and blood sugar control. It works best when combined with healthy eating, regular physical activity, and ongoing medical supervision.

#semaglutide #driadamedical #peptides #research #researchuseonly #laboratoryresearch #se #sem #pen #sem